TV 48108

Drug Profile

TV 48108

Alternative Names: 48108; TEV-48108; TV48108

Latest Information Update: 30 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Teva Branded Pharmaceutical Products R&D
  • Class Bronchodilators
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Chronic obstructive pulmonary disease

Most Recent Events

  • 27 Aug 2015 Teva terminates a phase I trial for Chronic obstructive pulmonary disease in USA, Australia and New Zealand (NCT02315144)
  • 01 Apr 2015 Phase-I clinical trials in Chronic obstructive pulmonary disease in New Zealand, Australia, USA (Inhalation)
  • 09 Dec 2014 Investigation in Chronic obstructive pulmonary disease in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top